For more than two decades, the biomedical company Pfizer has been working in the research and development of treatments to respond to the unmet medical needs of people living with rare diseases.

You can learn more about it here:

https://www.pfizer.es/noticia/pfizer_mendelian_presentan_una_plataforma_tecnologica_apoyar_profesionales_sanitarios_investigacion_diagnostico_enfermedades_raras.html



If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like Empowering doctors in rare disease diagnosis Mendelian receives over €570k for its rare disease diagnostics by Innovate UK Mendelian among the most innovative companies of the year by "El Pais".

Need help with a diagnosis?

Learn more about how to achieve it with Mendelian


Learn more